Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Maravai Lifesciences Holdings Inc Cl A (MRVI)

Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Maravai Lifesciences Reports First Quarter 2025 Financial Results

MRVI : 2.22 (-7.50%)
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

MRVI : 2.22 (-7.50%)
Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2024.

MRVI : 2.22 (-7.50%)
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

MRVI : 2.22 (-7.50%)
3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk

The stock market is in a bit of a tailspin of late as investors worry about the future of the economy. It can be a great idea to buy stocks on weakness if you're investing for the long term, but that doesn't...

VSCO : 22.77 (-3.23%)
NVDA : 136.31 (+1.44%)
SOUN : 10.07 (+1.00%)
MRVI : 2.22 (-7.50%)
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

MRVI : 2.22 (-7.50%)
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

MRVI : 2.22 (-7.50%)
Maravai LifeSciences Appoints R. Andrew Eckert as New Chairman of the Board Following Carl Hull's Retirement

Maravai LifeSciences announces Carl Hull's retirement as Executive Chairman, appointing R. Andrew Eckert as his successor.Quiver AI SummaryMaravai LifeSciences Holdings, Inc. announced the retirement of...

MRVI : 2.22 (-7.50%)
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

MRVI : 2.22 (-7.50%)
Maravai LifeSciences Announces November 2024 Investor Conference Schedule

MRVI : 2.22 (-7.50%)

Barchart Exclusives

Palo Alto’s ARR Growth Cools, But PANW Stock’s Valuation Stays Hot
Investors should weigh Palo Alto Network’s strong fundamentals against a valuation that leaves little room for error. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar